Discovery & Development

The war in Ukraine has massively impacted clinical trials. We spoke to one man tracking the disruption.

Clinical trials suffer from heavy dropout rates. Perhaps the answer is a little care and attention.

More researchers are exploring the potential of mRNA encapsulation into lipid nanoparticles.

What will drug development look like aboard a new commercial space station?

Advanced analytical technologies now offer the detailed assessments biopharma drug developers need.

This 6 episode miniseries will take listeners behind the scenes of a range of projects at the Drugs for Neglected Diseases initiative

How bioelectronic assays helped demonstrate the value of 3D iPSC cultures in modeling human brain development.

Are all antibiotics doomed to eventual impotence? New work from Oxford could change the game by defeating resistance itself.

Thorben Seeger wants to democratize the data held by the world’s leading genomic institutions. But what exactly does he mean by “democratize”?

Boston bioscientists have found an unlikely ally in anthrax toxins, which could form the basis for a new kind of painkiller.